Your browser doesn't support javascript.
loading
Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study.
Forså, Marianne I; Smedsrud, Marit K; Haugaa, Kristina H; Bjerring, Anders W; Früh, Andreas; Sarvari, Sebastian I; Landgraff, Hege W; Hallén, Jostein; Edvardsen, Thor.
Afiliación
  • Forså MI; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.
  • Smedsrud MK; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway.
  • Haugaa KH; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.
  • Bjerring AW; Department of Paediatric Cardiology, Oslo University Hospital, Rikshospitalet, PO Box 4950 Nydalen, Oslo NO-0424, Norway.
  • Früh A; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.
  • Sarvari SI; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway.
  • Landgraff HW; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.
  • Hallén J; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway.
  • Edvardsen T; Department of Paediatric Cardiology, Oslo University Hospital, Rikshospitalet, PO Box 4950 Nydalen, Oslo NO-0424, Norway.
Eur J Prev Cardiol ; 31(5): 591-598, 2024 Mar 27.
Article en En | MEDLINE | ID: mdl-37992187
It is important to distinguish exercise-induced cardiac left ventricular (LV) hypertrophy from hypertrophic cardiomyopathy (HCM), because athletes with HCM may have an increased risk of sudden cardiac death. Limited data are available on this distinction in adolescent athletes. Therefore, we performed a longitudinal observation study comparing the development of LV hypertrophy during adolescence in athletes and HCM genotype­positive patients. In early adolescence, LV hypertrophy was found in a similar proportion of athletes and HCM genotype­positive patients, with a potential grey zone ranging from a septum thickness Z-score of 2.0 to 3.3. After 3 years of follow-up, LV hypertrophy had progressed only in HCM genotype­positive patients, while athletes had larger LV volumes throughout the study period.Evaluation of LV volume and septum thickness progression may assist clinicians in distinguishing exercise-induced LV hypertrophy from early HCM disease in adolescents.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Hipertrofia Ventricular Izquierda Límite: Adolescent / Child / Humans Idioma: En Revista: Eur J Prev Cardiol Año: 2024 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Hipertrofia Ventricular Izquierda Límite: Adolescent / Child / Humans Idioma: En Revista: Eur J Prev Cardiol Año: 2024 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Reino Unido